Tags

Type your tag names separated by a space and hit enter

ACP Journal Club. Review: Metformin reduces risk for CV mortality compared with other oral diabetes drugs or placebo in type 2 diabetes.
Ann Intern Med 2009; 150(8):JC4-8AIM

Authors+Show Affiliations

University of Toronto, Toronto, Ontario, Canada.

Pub Type(s)

Comment
Journal Article

Language

eng

PubMed ID

19391221

Citation

Lipscombe, Lorraine. "ACP Journal Club. Review: Metformin Reduces Risk for CV Mortality Compared With Other Oral Diabetes Drugs or Placebo in Type 2 Diabetes." Annals of Internal Medicine, vol. 150, no. 8, 2009, pp. JC4-8.
Lipscombe L. ACP Journal Club. Review: Metformin reduces risk for CV mortality compared with other oral diabetes drugs or placebo in type 2 diabetes. Ann Intern Med. 2009;150(8):JC4-8.
Lipscombe, L. (2009). ACP Journal Club. Review: Metformin reduces risk for CV mortality compared with other oral diabetes drugs or placebo in type 2 diabetes. Annals of Internal Medicine, 150(8), pp. JC4-8.
Lipscombe L. ACP Journal Club. Review: Metformin Reduces Risk for CV Mortality Compared With Other Oral Diabetes Drugs or Placebo in Type 2 Diabetes. Ann Intern Med. 2009 Apr 21;150(8):JC4-8. PubMed PMID: 19391221.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - ACP Journal Club. Review: Metformin reduces risk for CV mortality compared with other oral diabetes drugs or placebo in type 2 diabetes. A1 - Lipscombe,Lorraine, PY - 2009/4/25/entrez PY - 2009/4/25/pubmed PY - 2009/4/25/medline SP - JC4 EP - 8 JF - Annals of internal medicine JO - Ann. Intern. Med. VL - 150 IS - 8 SN - 1539-3704 UR - https://www.unboundmedicine.com/medline/citation/19391221/ACP_Journal_Club__Review:_Metformin_reduces_risk_for_CV_mortality_compared_with_other_oral_diabetes_drugs_or_placebo_in_type_2_diabetes_ L2 - https://www.annals.org/aim/fullarticle/doi/10.7326/0003-4819-150-8-200904210-02008 DB - PRIME DP - Unbound Medicine ER -